BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38271200)

  • 1. GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the Pancreas.
    Lennartz M; Benjamin Dünnebier N; Höflmayer D; Dwertmann Rico S; Kind S; Reiswich V; Viehweger F; Lutz F; Fraune C; Gorbokon N; Luebke AM; Hube-Magg C; Büscheck F; Menz A; Uhlig R; Krech T; Hinsch A; Burandt E; Sauter G; Simon R; Kluth M; Steurer S; Marx AH; Lebok P; Dum D; Minner S; Jacobsen F; Clauditz TS; Bernreuther C
    Am J Surg Pathol; 2024 Apr; 48(4):377-386. PubMed ID: 38271200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100 Protein Expression in Primary and Metastatic Neuroendocrine Neoplasms: A Specific Marker of Pancreatic Origin.
    Pepper MA; Dulken BW; Wang Y; Zemek AJ; Martin BA; Charu V; Longacre TA
    Am J Surg Pathol; 2024 Feb; 48(2):157-162. PubMed ID: 37991258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas.
    Yoxtheimer LM; Heymann JJ; Cohen C; Rao RA; Goyal A; Siddiqui MT
    Diagn Cytopathol; 2018 Dec; 46(12):1010-1014. PubMed ID: 30284410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Differential diagnostic value of the expression of the transcription factor PDX-1 in neuroendocrine and non-neuroendocrine tumors of the pancreas and other organs].
    Gurevich LE; Proshchina AE; Voronkova IA; Ashevskaya VE; Korosteleva PA; Dolzhansky OV
    Arkh Patol; 2019; 81(5):11-21. PubMed ID: 31626200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet-1 Is Differentially Expressed Among Neuroendocrine and Non-Neuroendocrine Tumors and Its Potential Diagnostic Implication.
    Xiang Y; Malik F; Zhang PJ
    Int J Surg Pathol; 2023 Oct; 31(7):1294-1301. PubMed ID: 37796752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulinoma-associated protein 1 (INSM1) is a robust marker for identifying and grading pancreatic neuroendocrine tumors.
    Kim D; Viswanathan K; Goyal A; Rao R
    Cancer Cytopathol; 2020 Apr; 128(4):269-277. PubMed ID: 31977134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ISL1 expression is not restricted to pancreatic well-differentiated neuroendocrine neoplasms, but is also commonly found in well and poorly differentiated neuroendocrine neoplasms of extrapancreatic origin.
    Agaimy A; Erlenbach-Wünsch K; Konukiewitz B; Schmitt AM; Rieker RJ; Vieth M; Kiesewetter F; Hartmann A; Zamboni G; Perren A; Klöppel G
    Mod Pathol; 2013 Jul; 26(7):995-1003. PubMed ID: 23503646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOG1 (clone K9) is seldom expressed and not useful in the evaluation of pancreatic neoplasms.
    Hemminger J; Marsh WL; Iwenofu OH; Frankel WL
    Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):397-401. PubMed ID: 22495382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCD1 as a Novel Diagnostic Marker for Solid Pseudopapillary Neoplasm of the Pancreas.
    Liu YA; Liu Y; Tu J; Shi Y; Pang J; Huang Q; Wang X; Lin Z; Zhao Y; Wang W; Peng J; Wu W
    Am J Surg Pathol; 2024 May; 48(5):511-520. PubMed ID: 38567813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls.
    Konukiewitz B; Jesinghaus M; Kasajima A; Klöppel G
    Virchows Arch; 2022 Feb; 480(2):247-257. PubMed ID: 34647171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic Neuroendocrine Neoplasms to the Pancreas: Two Unusual Cases and a Review of the Literature.
    DelBaugh RM; Kerr DA; Dominguez-Konicki L; Beard JA; Gordon SR; Adler JM; Liu X
    Int J Surg Pathol; 2024 May; 32(3):523-532. PubMed ID: 37461216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours.
    Mohanty SK; Tiwari A; Bhardwaj N; Chuang F; Kim E; Lugo H; Yuan X; Diffalha SA; Peralta-Venturina M; Balzer B; Dhall D
    J Clin Pathol; 2021 Sep; 74(9):582-588. PubMed ID: 32934105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Ductal Tumors of the Pancreas.
    Dhillon J
    Monogr Clin Cytol; 2020; 26():92-108. PubMed ID: 32987393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14,000 neuroendocrine and non-neuroendocrine tumors.
    Möller K; Uhlig R; Gorbokon N; Dum D; Menz A; Büscheck F; Luebke AM; Hube-Magg C; Hinsch A; Höflmayer D; Fraune C; Lebok P; Weidemann S; Lennartz M; Jacobsen F; Clauditz TS; Steurer S; Burandt E; Krech R; Krech T; Marx AH; Sauter G; Simon R; Bernreuther C; Minner S
    Mol Cell Endocrinol; 2024 Feb; 581():112106. PubMed ID: 37951531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptor and PTEN expression predict survival in patients with low- and intermediate-grade pancreatic neuroendocrine tumors.
    Estrella JS; Broaddus RR; Mathews A; Milton DR; Yao JC; Wang H; Rashid A
    Arch Pathol Lab Med; 2014 Aug; 138(8):1027-36. PubMed ID: 25076292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases.
    Schmitt AM; Riniker F; Anlauf M; Schmid S; Soltermann A; Moch H; Heitz PU; Klöppel G; Komminoth P; Perren A
    Am J Surg Pathol; 2008 Mar; 32(3):420-5. PubMed ID: 18300808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical assessment of Pax8 expression during pancreatic islet development and in human neuroendocrine tumors.
    Lorenzo PI; Jimenez Moreno CM; Delgado I; Cobo-Vuilleumier N; Meier R; Gomez-Izquierdo L; Berney T; Garcia-Carbonero R; Rojas A; Gauthier BR
    Histochem Cell Biol; 2011 Nov; 136(5):595-607. PubMed ID: 21932072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SATB2 in neuroendocrine neoplasms: strong expression is restricted to well-differentiated tumours of lower gastrointestinal tract origin and is most frequent in Merkel cell carcinoma among poorly differentiated carcinomas.
    Bellizzi AM
    Histopathology; 2020 Jan; 76(2):251-264. PubMed ID: 31233624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine protease inhibitor 8 is a novel immunohistochemical marker for neuroendocrine tumors of the pancreas.
    de Koning PJ; Bovenschen N; Broekhuizen R; Lips CJ; Kummer JA
    Pancreas; 2009 May; 38(4):461-7. PubMed ID: 19188865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience.
    Rodriguez EF; Fite JJ; Chowsilpa S; Maleki Z
    Hum Pathol; 2019 Mar; 85():128-135. PubMed ID: 30502379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.